Your browser doesn't support javascript.
loading
Outcomes of anti-programmed death 1 treatment for relapsed/refractory Hodgkin lymphoma: A German Hodgkin Study Group multicentre real-world analysis.
Momotow, Jesko; Bühnen, Ina; Trautmann-Grill, Karolin; Kobbe, Guido; Hahn, Dennis; Schroers, Roland; Heinrich, Bernhard; Gaska, Tobias; Forstbauer, Helmut; Schmidt, Burkhard; Boger, Regina; Hüttmann, Andreas; Heil, Gerhard; Kraemer, Doris M; Krüger, William; Zeremski, Vanja; Grobe, Norbert; Jentsch-Ullrich, Kathleen; Griesinger, Frank; Fuchs, Michael; von Tresckow, Bastian; Borchmann, Peter; Engert, Andreas; Bröckelmann, Paul J.
Afiliação
  • Momotow J; Department I of Internal Medicine, Centre of Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Bühnen I; German Hodgkin Study Group (GHSG), Cologne, Germany.
  • Trautmann-Grill K; German Hodgkin Study Group (GHSG), Cologne, Germany.
  • Kobbe G; Medical Clinic I, University Hospital Dresden, Dresden, Germany.
  • Hahn D; University Hospital Duesseldorf, Duesseldorf, Germany.
  • Schroers R; Stuttgart General Hospital, Stuttgart, Germany.
  • Heinrich B; Knappschaftskrankenhaus Bochum, Bochum, Germany.
  • Gaska T; Hämatologisch-onkologische Praxis Heinrich/Bangerter, Augsburg, Germany.
  • Forstbauer H; Brüderkrankenhaus St. Josef Paderborn, Paderborn, Germany.
  • Schmidt B; Onkologie Rheinsieg, Troisdorf, Germany.
  • Boger R; Onkologie Pasing, Munich, Germany.
  • Hüttmann A; Hospital Schwarzwald-Baar, Villingen Schwenningen, Germany.
  • Heil G; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Kraemer DM; Klinikum Lüdenscheid, Germany.
  • Krüger W; St. Josefs-Hospital Hagen, Hagen, Germany.
  • Zeremski V; Klinik für Innere Medizin C - Hämatologie, Onkologie, Stammzelltransplantation, Palliativmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.
  • Grobe N; Department of Hematology and Oncology, Medical Center, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
  • Jentsch-Ullrich K; Dietrich-Bonhoeffer-Klinikum Neubrandenburg, Neubrandenburg, Germany.
  • Griesinger F; Onkologie Magdeburg, Magdeburg, Germany.
  • Fuchs M; Klinikum Oldenburg, Oldenburg, Germany.
  • von Tresckow B; Department I of Internal Medicine, Centre of Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), Faculty of Medicine and University Hospital of Cologne, University of Cologne, Cologne, Germany.
  • Borchmann P; German Hodgkin Study Group (GHSG), Cologne, Germany.
  • Engert A; German Hodgkin Study Group (GHSG), Cologne, Germany.
  • Bröckelmann PJ; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
Br J Haematol ; 198(2): 401-404, 2022 07.
Article em En | MEDLINE | ID: mdl-35538912
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Br J Haematol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha